World's Best Scientists 2026 revealed!
Award Badge
Immunology
Brazil
2026

D-Index & Metrics

Immunology

D-Index
92
Citations
25886
World Ranking
1013
National Ranking
5

Medicine

D-Index
93
Citations
26633
World Ranking
11008
National Ranking
26

Edgar M. Carvalho publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edgar M. Carvalho sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 468 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Edgar M. Carvalho D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edgar M. Carvalho sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Brazil Leader Award
  • 2025 - Research.com Immunology in Brazil Leader Award
  • 2023 - Research.com Immunology in Brazil Leader Award
  • 2022 - Research.com Immunology in Brazil Leader Award

Overview

Edgar M. Carvalho is affiliated with the Federal University of Bahia in Brazil and has an extensive publication record primarily in the fields of Medicine and Immunology and Microbiology. Their research spans across several subfields, including Public Health, Environmental and Occupational Health, Immunology, Epidemiology, Rheumatology, and Parasitology.

Their research focuses largely on infectious diseases, particularly leishmaniasis, with significant contributions to understanding the disease's pathogenesis and immune response mechanisms. Main topics explored by Carvalho include Research on Leishmaniasis Studies, Trypanosoma species research and implications, T-cell and Retrovirus Studies, Parasites and Host Interactions, Urticaria and Related Conditions, Eosinophilic Disorders and Syndromes, and Toxin Mechanisms and Immunotoxins.

Frequent co-authors in Carvalho's work include:

  • Lucas P. Carvalho
  • Paulo Roberto Lima Machado
  • Phillip Scott
  • Camila Farias Amorim
  • Sérgio Arruda

Carvalho has published frequently in several journals, with notable numbers of publications in these venues:

  • Frontiers in Immunology
  • Pathogens
  • Emerging Microbes & Infections
  • The Journal of Immunology
  • Clinical Infectious Diseases

Some recent papers by Edgar M. Carvalho, illustrating their research focus and contributions, include:

  • A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil, 2020, Clinical Infectious Diseases
  • Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity, 2023, Science Translational Medicine
  • Clinical Presentation and Response to Therapy in Children with Cutaneous Leishmaniasis, 2020, American Journal of Tropical Medicine and Hygiene
  • Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis, 2020, Frontiers in Immunology
  • Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis, 2021, Frontiers in Immunology

Carvalho's research combines clinical, molecular, and immunological methods to uncover both genetic and microbiota-related factors impacting cutaneous leishmaniasis outcomes. Their collaborative efforts show multidisciplinary engagement in addressing infectious disease mechanisms and potential therapeutic targets.

Best Publications

  • Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)*

    Naomi Aronson;Barbara L. Herwaldt;Michael Libman;Richard Pearson

  • New Perspectives on a Subclinical Form of Visceral Leishmaniasis

    R. Badaro;T. C. Jones;E. M. Carvalho;D. Sampaio

  • A Prospective Study of Visceral Leishmaniasis in an Endemic Area of Brazil

    R. Badaró;T. C. Jones;R. Lorenço;B. J. Cerf

  • Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients

    Olívia Bacellar;Hélio Lessa;Albert Schriefer;Paulo Machado

  • Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease.

    Barral A;Pedral-Sampaio D;Grimaldi Júnior G;Momen H

  • Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

    Edgar M. Carvalho;Roberto Badaro;Steven G. Reed;Thomas C. Jones

  • Impairment of Tetanus Toxoid-Specific Thl-like Immune Responses in Humans Infected with Schistosoma mansoni

    Elizabeth A. Sabin;Maria Ilma Araujo;Edgar M. Carvalho;Edward J. Pearce

  • Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

    Roberto Badaro;Ernesto Falcoff;Fernando S. Badaro;Edgar M. Carvalho

  • Cytokine profile and pathology in human leishmaniasis

    A Ribeiro-de-Jesus;R P Almeida;H Lessa;O Bacellar

  • Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.

    E M Carvalho;O Bacellar;C Brownell;T Regis

  • Clinical and Immunologic Evaluation of 31 Patients with Acute Schistosomiasis mansoni

    Amelia Ribeiro de Jesus;Angela Silva;Luciana B Santana;Andrea Magalhães

  • Epidemiological and clinical interaction between HTLV‐1 and Strongyloides stercoralis

    E. M. Carvalho;A. Da Fonseca Porto

  • Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

    Paulo R. Machado;Julia Ampuero;Luiz H. Guimarães;Leonardo Villasboas

  • Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

    E. M. Carvalho;W. D. Johnson;E. Barreto;P. D. Marsden

  • Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

    E M Carvalho;R S Teixeira;W D Johnson

  • Cutaneous Manifestations of Human and Murine Leishmaniasis.

    Breanna M Scorza;Edgar M Carvalho;Mary E Wilson

  • Inverse association between skin response to aeroallergens and Schistosoma mansoni infection.

    Maria Ilma Araujo;Antônio Alberto Lopes;Manoel Medeiros;Álvaro A. Cruz

  • Disseminated Leishmaniasis: A New and Emerging Form of Leishmaniasis Observed in Northeastern Brazil

    Meredith L. Turetz;Paulo R. Machado;Albert I. Ko;Albert I. Ko;Fábio Alves

  • Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

    Daniela R. Faria;Kenneth J. Gollob;José Barbosa;José Barbosa;Albert Schriefer

  • Comparação da propensão de quedas entre idosos que praticam atividade física e os idosos sedentários

    Lhct. Guimarães;Dca Galdino;Flm Martins;Dfm Vitorino

  • Schistosoma mansoni infection is associated with a reduced course of asthma.

    Manoel Medeiros;Joanemile P. Figueiredo;Maria C. Almeida;Maria Analia Matos

Frequent Co-Authors

Aldina Barral
Aldina Barral Oswaldo Cruz Foundation
Manoel Barral-Netto
Manoel Barral-Netto Oswaldo Cruz Foundation
Roberto Badaró
Roberto Badaró Federal University of Bahia
Warren D. Johnson
Warren D. Johnson Cornell University
Marshall J. Glesby
Marshall J. Glesby Cornell University
Mary E. Wilson
Mary E. Wilson University of California, San Francisco
Phillip Scott
Phillip Scott University of Pennsylvania
Alvaro A. Cruz
Alvaro A. Cruz Federal University of Bahia
Sergio C. Oliveira
Sergio C. Oliveira Universidade de São Paulo
Jenefer M. Blackwell
Jenefer M. Blackwell Telethon Kids Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens numerous doors to related healthcare fields, especially within nursing and advanced practice roles. Many students consider accelerated pathways to transition into nursing quickly, making an accelerated nurse practitioner program an attractive option. These programs equip students with advanced clinical skills in a reduced timeframe, ideal for those aiming to integrate immunology knowledge in patient care.

For individuals without a nursing background, enrolling in the best online BSN programs for non nurses provides a supportive route to enter the profession. Such programs emphasize foundational nursing concepts alongside specialized courses that complement immunology studies.

If gaining admission poses challenges, exploring the easiest accelerated nursing programs can provide an accessible way to start a healthcare career relevant to immunology. These programs prioritize streamlined admission processes while maintaining essential training quality.

Additionally, those seeking quicker entry into nursing roles might consider LPN programs with easiest admission requirements. Licensed Practical Nurse programs offer a practical approach to begin hands-on work in healthcare environments where immunological knowledge is valuable in managing patient care.

Best Scientists Citing Edgar M. Carvalho

Trending Scientists

Recently Published Articles